Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Nesfatin-1 could be a strong candidate obesity or diabetes medication, if blood pressure elevation can be controlled.

Masuo K.

Hypertens Res. 2014 Feb;37(2):98-9. doi: 10.1038/hr.2013.152. Epub 2013 Nov 7. No abstract available.

PMID:
24196198
2.

Peripheral administration of nesfatin-1 increases blood pressure in mice.

Osaki A, Shimizu H.

Hypertens Res. 2014 Feb;37(2):185-6. doi: 10.1038/hr.2013.122. Epub 2013 Sep 19. No abstract available.

PMID:
24048489
3.

Multi-functional peptide hormone NUCB2/nesfatin-1.

Aydin S.

Endocrine. 2013 Oct;44(2):312-25. doi: 10.1007/s12020-013-9923-0. Epub 2013 Mar 23. Review.

PMID:
23526235
4.

A novel adipocytokine, nesfatin-1 modulates peripheral arterial contractility and blood pressure in rats.

Yamawaki H, Takahashi M, Mukohda M, Morita T, Okada M, Hara Y.

Biochem Biophys Res Commun. 2012 Feb 24;418(4):676-81. doi: 10.1016/j.bbrc.2012.01.076. Epub 2012 Jan 24.

PMID:
22293188
5.

More news about NUCB2/nesfatin-1: a new factor in the hypothalamic control of glucose homeostasis?

Butler AA.

Diabetes. 2012 Aug;61(8):1920-2. doi: 10.2337/db12-0576. No abstract available.

6.

Peripheral effects of nesfatin-1 on glucose homeostasis.

Li Z, Gao L, Tang H, Yin Y, Xiang X, Li Y, Zhao J, Mulholland M, Zhang W.

PLoS One. 2013 Aug 15;8(8):e71513. doi: 10.1371/journal.pone.0071513. eCollection 2013.

7.

Nesfatin-1 exerts long-term effect on food intake and body temperature.

Könczöl K, Pintér O, Ferenczi S, Varga J, Kovács K, Palkovits M, Zelena D, Tóth ZE.

Int J Obes (Lond). 2012 Dec;36(12):1514-21. doi: 10.1038/ijo.2012.2. Epub 2012 Jan 31.

PMID:
22290539
8.

Nesfatin-1 inhibits gastric acid secretion via a central vagal mechanism in rats.

Xia ZF, Fritze DM, Li JY, Chai B, Zhang C, Zhang W, Mulholland MW.

Am J Physiol Gastrointest Liver Physiol. 2012 Sep 1;303(5):G570-7. doi: 10.1152/ajpgi.00178.2012. Epub 2012 Jun 21.

9.

Nesfatin-1 influences the excitability of glucosensing neurons in the hypothalamic nuclei and inhibits the food intake.

Chen X, Dong J, Jiang ZY.

Regul Pept. 2012 Aug 20;177(1-3):21-6. doi: 10.1016/j.regpep.2012.04.003. Epub 2012 May 2.

PMID:
22561448
10.

Nesfatin-1 action in the brain increases insulin sensitivity through Akt/AMPK/TORC2 pathway in diet-induced insulin resistance.

Yang M, Zhang Z, Wang C, Li K, Li S, Boden G, Li L, Yang G.

Diabetes. 2012 Aug;61(8):1959-68. doi: 10.2337/db11-1755. Epub 2012 Jun 11.

11.

Nesfatin-1/NUCB2 may participate in the activation of the hypothalamic-pituitary-adrenal axis in rats.

Könczöl K, Bodnár I, Zelena D, Pintér O, Papp RS, Palkovits M, Nagy GM, Tóth ZE.

Neurochem Int. 2010 Oct;57(3):189-97. doi: 10.1016/j.neuint.2010.04.012. Epub 2010 May 6.

PMID:
20435076
12.

Central nesfatin-1 influences the excitability of ghrelin-responsive gastric distension neurons in the arcuate nucleus and reduces gastric motility in rats.

Li ZL, Xu L, Sun XR, Guo FF, Gong YL, Gao SL.

Eur J Neurosci. 2013 Dec;38(11):3636-43. doi: 10.1111/ejn.12366. Epub 2013 Sep 23.

PMID:
24289827
13.

Nesfatin-1(30-59) but not the N- and C-terminal fragments, nesfatin-1(1-29) and nesfatin-1(60-82) injected intracerebroventricularly decreases dark phase food intake by increasing inter-meal intervals in mice.

Stengel A, Goebel-Stengel M, Wang L, Kato I, Mori M, Taché Y.

Peptides. 2012 Jun;35(2):143-8. doi: 10.1016/j.peptides.2012.03.015. Epub 2012 Mar 28.

14.

Nesfatin-1 suppresses energy intake, co-localises ghrelin in the brain and gut, and alters ghrelin, cholecystokinin and orexin mRNA expression in goldfish.

Kerbel B, Unniappan S.

J Neuroendocrinol. 2012 Feb;24(2):366-77. doi: 10.1111/j.1365-2826.2011.02246.x.

PMID:
22023656
15.

New satiety hormone nesfatin-1 protects gastric mucosa against stress-induced injury: mechanistic roles of prostaglandins, nitric oxide, sensory nerves and vanilloid receptors.

Szlachcic A, Sliwowski Z, Krzysiek-Maczka G, Majka J, Surmiak M, Pajdo R, Drozdowicz D, Konturek SJ, Brzozowski T.

Peptides. 2013 Nov;49:9-20. doi: 10.1016/j.peptides.2013.07.017. Epub 2013 Aug 24.

PMID:
23978788
16.

Nesfatin-1 as a new positive inotrope in the goldfish (Carassius auratus) heart.

Mazza R, Gattuso A, Filice M, Cantafio P, Cerra MC, Angelone T, Imbrogno S.

Gen Comp Endocrinol. 2015 Dec 1;224:160-7. doi: 10.1016/j.ygcen.2015.08.003. Epub 2015 Aug 4.

PMID:
26248227
17.

Nesfatin-1 induces the phosphorylation levels of cAMP response element-binding protein for intracellular signaling in a neural cell line.

Ishida E, Hashimoto K, Shimizu H, Okada S, Satoh T, Kato I, Yamada M, Mori M.

PLoS One. 2012;7(12):e50918. doi: 10.1371/journal.pone.0050918. Epub 2012 Dec 6.

18.

Nesfatin-1, a unique regulatory neuropeptide of the brain.

Pałasz A, Krzystanek M, Worthington J, Czajkowska B, Kostro K, Wiaderkiewicz R, Bajor G.

Neuropeptides. 2012 Jun;46(3):105-12. doi: 10.1016/j.npep.2011.12.002. Epub 2012 Jan 5.

PMID:
22225987
19.

Effects of nesfatin-1 on food intake and LH secretion in prepubertal gilts and genomic association of the porcine NUCB2 gene with growth traits.

Lents CA, Barb CR, Hausman GJ, Nonneman D, Heidorn NL, Cisse RS, Azain MJ.

Domest Anim Endocrinol. 2013 Aug;45(2):89-97. doi: 10.1016/j.domaniend.2013.06.002. Epub 2013 Jun 22.

PMID:
23820242
20.

Identification of nesfatin-1 as a satiety molecule in the hypothalamus.

Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, Yamada M, Mori M.

Nature. 2006 Oct 12;443(7112):709-12. Epub 2006 Oct 1.

PMID:
17036007

Supplemental Content

Support Center